Botulinum toxin A in the treatment of chromhidrosis

Dermatologic Surgery

Volumn 31, Issue 8 PART 1, 2005, Pages 963-965

  Wu, Jessie M ^a   Mamelak, Adam J ^b   Nussbaum, Rachel ^b   McElgunn, Patrick S J ^b,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Green Spring Station   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM CHLORIDE; BOTULINUM TOXIN A; CAPSAICIN; SUBSTANCE P; BOTULINUM TOXIN; MUSCLE RELAXANT AGENT;

ADRENERGIC STIMULATION; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHOLINERGIC STIMULATION; CHROMHIDROSIS; CLINICAL FEATURE; CREAM; DRUG FORMULATION; FEMALE; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUNCH BIOPSY; SWEAT GLAND DISEASE; TREATMENT OUTCOME; CHEEK; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; PIGMENT DISORDER; RECURRENT DISEASE;

ADULT; BOTULINUM TOXINS; CHEEK; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; NEUROMUSCULAR AGENTS; PIGMENTATION DISORDERS; RECURRENCE; SWEAT GLAND DISEASES;

EID: 24044528888     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2005.31814     Document Type: Article

References (15)

1. Chromhidrosis. In: Odom RB, James WD, Berger TG, editors. Andrews' disease of the skin: clinical dermatology. 9th ed. Philadelphia: WB Saunders; 2000. p. 975.
2. Shelley WB, Hurley HJ. Localized chromhidrosis: a survey. Arch Dermatol 1954;69:449-71.
3. Barankin B, Alanen K, Ting PT, Sapijaszko MJ. Bilateral facial apocrine chromhidrosis. J Drugs Dermatol 2004;3:184-6.
4. Hurley HJ Jr. Apocrine chromhidrosis. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. 6th ed. New York: McGraw-Hill; 2003. p. 708-9.
5. Robertshaw D. Catecholamines and the control of sweat glands. In: Blaschko H, Sayers G, Smith AD, editors. Handbook of physiology, endocrinology, VI. Washington (DC): American Physiology Society; 1975. p. 591-603.
6. Rumsfield JA, West DP. Topical capsaicin in dermatologic and peripheral pain disorders. DICP Ann Pharmacother 1991;25:381-7.
7. Marks JG Jr. Treatment of apocrine chromhidrosis with topical capsaicin. J Am Acad Dermatol 1989;21(2 Pt 2):418-20.
8. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001;15:323:596-9.
9. Heckmann M, Teichmann B, Pause BM, Plewig G. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A. Arch Dermatol 2003;139:57-9.
10. Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003;43 Suppl 1:59-15.
11. Sheean G. Botulinum toxin for the treatment of musculoskeletal pain and spasm. Curr Pain Headache Rep 2002;6:460-9.
12. Shelley WB, Hurely HJ. The physiology of the human axillary apocrine sweat glands. J Invest Dermatol 1953;20:285-95.
13. Aoki T. Stimulation of human axillary apocrine sweat glands by cholinergic agents. J Invest Dermatol 1962;38:41-4.
14. Uno H. Sympathetic innervation of the sweat glands and piloarrector muscles of macaques and human beings. J Invest Dermatol 1977;69:112-20.
15. Habermann E, Dreyer F. Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr Top Microbiol Immunol 1986;129:94-179.